Conmed CNMD
NYSE CNMD
$51.37 +0.12 (+0.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Conmed (CNMD) Cash from Operations Growth (3y) (2013 - 2026)

Conmed (CNMD) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 27.41%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 22.38%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 1.51%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 30.85%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 168.71%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 12.26%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 65.19%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 43.79%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 9.30%
10 Conmed 1.54 Bn 1.50 Bn 197.46 Mn 11.62%

Historic Data

Download Data
DateValue
Jun 30, 2026 11.62%
Mar 31, 2026 76.54%
Dec 31, 2025 81.66%
Sep 30, 2025 27.51%
Jun 30, 2025 15.84%
Mar 31, 2025 402.16%
Dec 31, 2024 8.65%
Sep 30, 2024 33.83%
Jun 30, 2024 8.10%
Mar 31, 2024 9.23%
Dec 31, 2023 40.94%
Sep 30, 2023 9.51%
Jun 30, 2023 68.87%
Mar 31, 2023 -44.77%
Dec 31, 2022 -31.69%
Sep 30, 2022 -10.90%
Jun 30, 2022 -4.59%
Mar 31, 2022 27.73%
Dec 31, 2021 11.00%
Sep 30, 2021 69.96%